ISG15: a ubiquitin-like enigma

作者: Chinh T Dao , Dong-Er Zhang

DOI: 10.2741/1730

关键词:

摘要: ISG15 is a 17 kDa protein encoded by an interferon stimulated gene. Described in 1979, it was the first ubiquitin-like modifier to be identified, and its discovery followed reports of ubiquitin only four years. While many important functions for have been reported, conjugation are still largely unknown. Evidence suggests that modification system play roles innate immune response, regulation signaling, pregnancy, several cancers. Modification proteins occurs manner similar other modifiers. The enzymes which help perform activation recently identified. enzyme identified revealed also involved conjugation. Identification specific protease has reported. Knockout this mice decreases lifespan these makes them hypersensitive treatment with or lipopolysaccharide. study may yield set potentially useful therapeutic targets thus, there increasing awareness interest modifier. This review will highlight history discovery, describe more recent observations about modification, summarize new findings implications signal transduction immunology. point out questions remain answered identify major roadblocks currently obstruct understanding biologic functions.

参考文章(179)
S J Grenfell, J S Trausch-Azar, P M Handley-Gearhart, A Ciechanover, A L Schwartz, Nuclear localization of the ubiquitin-activating enzyme, E1, is cell-cycle-dependent. Biochemical Journal. ,vol. 300, pp. 701- 708 ,(1994) , 10.1042/BJ3000701
A. Rubartelli, F. Cozzolino, M. Talio, R. Sitia, A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. The EMBO Journal. ,vol. 9, pp. 1503- 1510 ,(1990) , 10.1002/J.1460-2075.1990.TB08268.X
I.N. Hampson, L. Hampson, M. Pinkoski, M. Cross, C.M. Heyworth, R.C. Bleackley, E. Atkinson, T.M. Dexter, Identification of a Serpin Specifically Expressed in Multipotent and Bipotent Hematopoietic Progenitor Cells and in Activated T Cells Blood. ,vol. 89, pp. 108- 118 ,(1997) , 10.1182/BLOOD.V89.1.108
R. Brem, K. Oraszlan-Szovik, S. Foser, B. Bohrmann, U. Certa, Inhibition of proliferation by 1-8U in interferon-α-responsive and non-responsive cell lines Cellular and Molecular Life Sciences. ,vol. 60, pp. 1235- 1248 ,(2003) , 10.1007/S00018-003-3016-9
S. R. McKercher, B. E. Torbett, K. L. Anderson, G. W. Henkel, D. J. Vestal, H. Baribault, M. Klemsz, A. J. Feeney, G. E. Wu, C. J. Paige, R. A. Maki, Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. The EMBO Journal. ,vol. 15, pp. 5647- 5658 ,(1996) , 10.1002/J.1460-2075.1996.TB00949.X
N. Blumenfeld, H. Gonen, A. Mayer, C.E. Smith, N.R. Siegel, A.L. Schwartz, A. Ciechanover, Purification and characterization of a novel species of ubiquitin-carrier protein, E2, that is involved in degradation of non-"N-end rule" protein substrates. Journal of Biological Chemistry. ,vol. 269, pp. 9574- 9581 ,(1994) , 10.1016/S0021-9258(17)36920-X
K.R. Loeb, A.L. Haas, The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. Journal of Biological Chemistry. ,vol. 267, pp. 7806- 7813 ,(1992) , 10.1016/S0021-9258(18)42585-9
Paul Travers, Charles A Janeway, Mark Walport, Mark J Shlomchik, The Immune System in Health and Disease Garland Science. ,(2001)
Daniel G. Tenen, Robert Hromas, Jonathan D. Licht, Dong-Er Zhang, Transcription factors, normal myeloid development, and leukemia. Blood. ,vol. 90, pp. 489- 519 ,(1997) , 10.1182/BLOOD.V90.2.489.489_489_519
E. M. DeMaeyer, Jaqueline De Maeyer-Guignard, Interferons and other regulatory cytokines Wiley. ,(1988)